Blue Trust Inc. Sells 2,039 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Blue Trust Inc. reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 19.6% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 8,390 shares of the healthcare conglomerate’s stock after selling 2,039 shares during the period. Blue Trust Inc.’s holdings in UnitedHealth Group were worth $4,244,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. AlphaMark Advisors LLC acquired a new stake in UnitedHealth Group during the 4th quarter worth about $30,000. RPg Family Wealth Advisory LLC acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $37,000. Friedenthal Financial acquired a new stake in UnitedHealth Group during the 3rd quarter worth about $51,000. Highline Wealth Partners LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $55,000. Finally, Legacy Investment Solutions LLC acquired a new stake in shares of UnitedHealth Group in the 3rd quarter valued at about $57,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently commented on UNH shares. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a research note on Friday, January 17th. Hsbc Global Res upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft lifted their price target on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a research note on Tuesday, December 3rd. Oppenheimer lifted their price target on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Finally, Truist Financial cut their price target on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating for the company in a research note on Monday, January 6th. One analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, UnitedHealth Group currently has an average rating of “Buy” and a consensus price target of $629.32.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn bought 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of UNH opened at $523.48 on Friday. The stock’s fifty day moving average price is $523.63 and its two-hundred day moving average price is $563.48. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The firm has a market cap of $481.75 billion, a PE ratio of 33.77, a PEG ratio of 1.45 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping the consensus estimate of $6.74 by $0.07. The firm had revenue of $100.81 billion during the quarter, compared to the consensus estimate of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter last year, the company earned $5.83 earnings per share. On average, equities research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.